[{"title": "Electrocardiographic strain and relationship with LV remodelling and clinical outcomes in patients with aortic stenosis undergoing transcatheter aortic valve \u2026", "link": "https://karger.com/crd/article-abstract/doi/10.1159/000542529", "details": "D Wasim, A Mohamed Ali, \u00d8 Bleie, KH L\u00f8land\u2026 - Cardiology, 2024", "abstract": "Introduction: Left ventricular (LV) remodelling and fibrosis is known to occur in patients with aortic stenosis (AS) and is linked to post-intervention outcomes. These myocardial changes may be detected upon the routine 12-lead electrocardiogram by \u2026"}, {"title": "Metabolic and Pharmacokinetic Profiling of an Exogenous Ketone Ester by Background SGLT2 Inhibitor Therapy in Heart Failure with Reduced Ejection", "link": "https://www.sciencedirect.com/science/article/pii/S2452302X24003930/pdf%3Fmd5%3D349c499b9899dc92cffc207357144db4%26pid%3D1-s2.0-S2452302X24003930-main.pdf", "details": "S Selvaraj, LC Kwee, EJ Thompson, M He, CP Hornik\u2026 - JACC: Basic to Translational \u2026, 2024", "abstract": "Growing evidence supports ketosis in HFrEF, though uncertainty exists regarding use with SGLT2i and dose-dependent effects. In a phase I trial of two KE doses in 20 HFrEF participants, stratified by background SGLT2i, we detailed pharmacokinetic \u2026"}, {"title": "Cardiac magnetic resonance markers of pre-clinical hypertrophic and dilated cardiomyopathy in genetic variant carriers", "link": "https://www.medrxiv.org/content/medrxiv/early/2024/11/15/2024.11.15.24317368.full.pdf", "details": "PM Croon, M van Vugt, CP Allaart, B Ruijsink\u2026 - medRxiv, 2024", "abstract": "Background. Patients with hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) exhibit structural and functional cardiac abnormalities. We aimed to identify imaging biomarkers for pre-clinical cardiomyopathy in healthy \u2026"}]
